Menu Close

Articles on COVID-19 research

Displaying all articles

This antibody adopts a Y-shape. The arms of the Y make up the part of the antibody that binds to the target. ALFRED PASIEKA/SCIENCE PHOTO LIBRARY

One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19

Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
By setting out the continent’s research priorities, scientists can focus better on what needs to be done. Maliutina Anna/Shutterstock

Africa’s scientists set out their COVID-19 research priorities

Some of the priorities were drawn from the World Health Organisation's Roadmap; others were expressed by researchers in and from Africa as being important to the continent's many contexts.

Top contributors